Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

Blood (2010) 116 (22): 4693–4699.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals